ストックスクリーナーアプリを入手
1.47
2.08%
0.03
プレマーケット:
1.44
-0.03
-2.04%
前日終値:
$1.44
開ける：
$1.44
24時間の取引高:
484.29K
Relative Volume:
0.49
時価総額：
$86.23M
収益：
-
当期純損益:
$-22.40M
株価収益率:
-2.0946
EPS:
-0.7018
ネットキャッシュフロー:
$-18.84M
1週間 パフォーマンス:
-1.34%
1か月 パフォーマンス:
-36.64%
6か月 パフォーマンス:
-6.37%
1年 パフォーマンス:
-6.37%
1日の値動き範囲:
$1.43
$1.51
1週間の範囲:
$1.41
$1.51
52週間の値動き範囲:
$0.87
$3.19
MAIA Biotechnology Inc Stock (MAIA) Company Profile
名前
MAIA Biotechnology Inc
セクター
電話
312 416 8592
住所
444 West Lake Street, Suite 1700, Chicago
Compare MAIA vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.47 | 84.47M | 0 | -22.40M | -18.84M | -0.7018 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
MAIA Biotechnology Inc (MAIA) 最新ニュース
MAIA Biotechnology, Inc. 2025 Annual 10-K SEC Filing Overview: Private Placements, Warrants, and Equity Transactions - Minichart
MAIA Biotechnology (NYSEAMERICAN:MAIA) Releases Quarterly Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
MAIA Biotechnology 10-K: Operating loss $24.27M, Net loss $22.40M; Cash $8.66M - TradingView
MAIA: Advanced clinical pipeline and $33M capital raise position company for pivotal 2026 milestones - TradingView
MAIA Biotechnology (MAIA) advances ateganosine with Fast Track and Phase 3 NSCLC trial - Stock Titan
Market Review: Will MAIA Biotechnology Inc outperform small cap indexes2026 Market WrapUp & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Fundamentals Check: What are the future prospects of MAIA Biotechnology IncPortfolio Update Report & AI Driven Price Forecasts - baoquankhu1.vn
Short Interest in MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Expands By 17.9% - MarketBeat
MAIA Biotechnology (MAIA) Expected to Announce Quarterly Earnings on Friday - Defense World
MAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Up 0.7%Still a Buy? - MarketBeat
MAIA Earnings History & Surprises | EPS & Revenue Results | MAIA BIOTECHNOLOGY INC (NYSEARCA:MAIA) - ChartMill
Is the Market Bullish or Bearish on MAIA Biotechnology Inc? - Sahm
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock - Sahm
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) - GlobeNewswire Inc.
MAIA Biotechnology Completes $30 Million Public Stock Offering - TipRanks
Maia Biotechnology Inc enters underwriting agreement with Konik Capital PartnersSEC filing - marketscreener.com
Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital PartnersSEC Filing - TradingView
MAIA Biotechnology Prices $30 Million Offering of 20 Million Shares at $1.50 - TradingView
MAIA Biotechnology (NYSE American: MAIA) closes $30M common stock raise - Stock Titan
[424B5] MAIA Biotechnology, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
MAIA Shares Fall After Pricing of $30 Million Public Offering - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
MAIA Biotechnology shares drop 29% on discounted stock offering By Investing.com - Investing.com Canada
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock - The Manila Times
Cancer immunotherapy firm MAIA raises $30M for trials, costs - Stock Titan
MAIA Biotechnology Prices $30 Mln Public Offering Of Shares At $1.50/shr; Stock Down - Nasdaq
MAIA Biotechnology (NYSE: MAIA) offers common stock and pre-funded warrants - Stock Titan
Cancer immunotherapy developer MAIA plans stock sale to fund trials - Stock Titan
MAIA Should I Buy - Intellectia AI
MAIAMAIA Biotechnology Inc. Latest Stock News & Market Updates - Stock Titan
MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program - TipRanks
MAIA Biotechnology cites Phase 3 momentum for ateganosine, targets $50B immunotherapy market - TradingView
MAIA Biotechnology (NYSE: MAIA) touts Phase 3 NSCLC drug and Fast Track - Stock Titan
MAIA Biotechnology : Shareholder Letter - marketscreener.com
MAIA Biotechnology’s Phase 3 Momentum Demonstrates - GlobeNewswire
Portfolio Update: Can MAIA Biotechnology Inc grow without dilutionJuly 2025 Earnings & Weekly High Potential Stock Alerts - baoquankhu1.vn
MAIA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MACD Signal: How does Franklin Wireless Corp perform in inflationary periodsPortfolio Value Report & Fast Entry Momentum Alerts - baoquankhu1.vn
Quarterly Recap: What is the next catalyst for MAIA Biotechnology IncGlobal Markets & Accurate Buy Signal Alerts - baoquankhu1.vn
MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Sees Significant Growth in Short Interest - MarketBeat
Whale Trades: How do insiders feel about MAIA Biotechnology IncWeekly Profit Analysis & Verified Technical Signals - baoquankhu1.vn
Weekly Recap: What is the next catalyst for MAIA Biotechnology IncMarket Growth Review & Long-Term Safe Return Strategies - baoquankhu1.vn
MAIA’s New Agreement With Big Pharma Roche Turns Retail Investors Bullish As Stock Soars - MSN
Why MAIA Biotechnology Inc. stock could benefit from AI revolution2025 Trading Volume Trends & Stepwise Trade Execution Plans - mfd.ru
MAIA Technical Analysis & Stock Price Forecast - Intellectia AI
Does MAIA Biotechnology Inc. have pricing power2025 Performance Recap & Low Risk High Win Rate Picks - mfd.ru
What’s the MACD signal for MAIA Biotechnology Inc.2025 Macro Impact & Low Risk High Win Rate Stock Picks - mfd.ru
Is MAIA Biotechnology Inc. showing insider buying2025 EndofYear Setup & Weekly High Return Forecasts - mfd.ru
Is MAIA Biotechnology Inc. stock showing strong momentumGDP Growth & Real-Time Sentiment Analysis - mfd.ru
What are the future prospects of MAIA Biotechnology IncSwing Trade & Daily Technical Forecast Reports - baoquankhu1.vn
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 0.5%Should You Buy? - MarketBeat
MAIA Biotechnology Inc (MAIA) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):